Novacare Drug Specialities Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.84 M
as on 24-10-2024
- Company Age 32 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.07 Cr
as on 24-10-2024
- Satisfied Charges ₹ 32.68 Cr
as on 24-10-2024
- Revenue -71.25%
(FY 2023)
- Profit -34.97%
(FY 2023)
- Ebitda 36.29%
(FY 2023)
- Net Worth 3.07%
(FY 2023)
- Total Assets -5.73%
(FY 2023)
About Novacare Drug Specialities
The Corporate was formerly known as Novacare Drug Specialities Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.84 M.
The company currently has active open charges totaling ₹1.07 Cr. The company has closed loans amounting to ₹32.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramakrishnan Kannan and Hema Kannan serve as directors at the Company.
- CIN/LLPIN
U24239MH1992PTC067417
- Company No.
067417
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Novacare Drug Specialities?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakrishnan Kannan  | Managing Director | 25-Jun-1992 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hema Kannan | Director | 03-Nov-2006 | Current |
Financial Performance of Novacare Drug Specialities.
Novacare Drug Specialities Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 71.25% decrease. The company also saw a substantial fall in profitability, with a 34.97% decrease in profit. The company's net worth moved up by a moderate rise of 3.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novacare Drug Specialities?
In 2023, Novacare Drug Specialities had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Novacare Packaging Private LimitedActive 25 years 8 months
Ramakrishnan Kannan and Hema Kannan are mutual person
- Medworld Pharmaceuticals Private LimitedActive 18 years 6 months
Ramakrishnan Kannan and Hema Kannan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 May 2017 | ₹0.44 M | Open |
Others Creation Date: 13 Nov 2015 | ₹1.28 M | Open |
Hdfc Bank Limited Creation Date: 31 Jul 2012 | ₹5.00 M | Open |
How Many Employees Work at Novacare Drug Specialities?
Novacare Drug Specialities has a workforce of 267 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novacare Drug Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novacare Drug Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
